One of our VPs for Physician Services and a Pharmacy Clinical Coordinator have concerns about the antibiotic choices for the CMS requirements vs the IDSA guidelines in regards to intra-abdominal source of infection and UTI when there is a severe beta-lactam allergy. One concern (intra-abd source) is that Flagyl must be given with 2 other antibiotics if given which could lead to a patient getting unnecessary antibiotics. The second is, if the source of infection is urinary and most common pathogens are gram negative, Ciprofloxacin is not a "monotherapy" agent per CMS. For IDSA, Linezolid and Daptomycin would not be encouraged to use for this scenario and other agents such as Clindamycin and macrolides are not used for urinary source of infection. Does anyone have any clarification for this that I could bring back to my physicians and pharmacy coordinators? Thank you!
Amy Cobb RN, BSN Sepsis Coordinator/ICU Tracker Research Outcomes Morton Plant Hospital MS #73 300 Pinellas St. Clearwater, FL 33756 727-298-6953 (Desk) 727-462-3638 (Fax) [email protected]<mailto:[email protected]> ---------------------------------------------------------------------- Confidential: This electronic message and all contents contain information from BayCare Health System which may be privileged, confidential or otherwise protected from disclosure. The information is intended to be for the addressee only. If you are not the addressee, any disclosure, copy, distribution or use of the contents of this message is prohibited. If you have received this electronic message in error, please notify the sender and destroy the original message and all copies.
_______________________________________________ Sepsisgroups mailing list [email protected] http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
